Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 30Glioblastoma 28Breast Neoplasms 19Lung Neoplasms 17Carcinoma, Non-Small-Cell Lung 17Oropharyngeal Neoplasms 14Squamous Cell Carcinoma of Head and Neck 11Sarcoma 10Glioma 10Esophageal Neoplasms 10Brain Neoplasms 10Urinary Bladder Neoplasms 9Astrocytoma 9Gliosarcoma 8Triple Negative Breast Neoplasms 7Neoplasm Metastasis 7Mouth Neoplasms 7Uterine Cervical Neoplasms 6Rectal Neoplasms 6Melanoma 6Head and Neck Neoplasms 6Carcinoma, Hepatocellular 6Carcinoma 6Adenocarcinoma Of Esophagus 6Stomach Neoplasms 5Pancreatic Neoplasms 5Neoplasms 5Laryngeal Neoplasms 5Esophageal Squamous Cell Carcinoma 5Carcinoma, Squamous Cell 5

Interventions

Paclitaxel 7Cyclophosphamide 6Doxorubicin 5pembrolizumab 3Trastuzumab 3Taxes 3Specimen Handling 3Carboplatin 3pertuzumab 2eribulin 2Radiotherapy 2Epirubicin 2Docetaxel 2trastuzumab deruxtecan 1trastuzumab biosimilar HLX02 1ruxolitinib 1pegfilgrastim 1onvansertib 1olaparib 1neratinib 1durvalumab 1cobimetinib 1atezolizumab 1X-Rays 1Therapeutics 1Tamoxifen 1Surgical Procedures, Operative 1Radiation 1Peripheral Blood Stem Cell Transplantation 1Panitumumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Inflammatory Breast Neoplasms × Radiation × 1 year × Clear all
NCT03598257 2026-05-13

Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
300 enrolled
Breast

Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡